Bevacizumab(Avastin) Induced Hypertension and Correlation With Tumor Response, a Chart Review

Trial Profile

Bevacizumab(Avastin) Induced Hypertension and Correlation With Tumor Response, a Chart Review

Completed
Phase of Trial: Phase IV

Latest Information Update: 29 Feb 2016

At a glance

  • Drugs Bevacizumab (Primary) ; Antineoplastics
  • Indications Cancer metastases
  • Focus Therapeutic Use
  • Most Recent Events

    • 24 Feb 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 16 Oct 2008 Inclusion criteria amended as reported by ClinicalTrials.gov.
    • 01 Oct 2008 Planned end date (Feb 2011) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top